AIM
LOXO

Acrospire Investment Management’s Loxo Oncology, Inc LOXO Stock Holding History

Acrospire Investment Management’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-98
Closed -$2K – 2284
2016
Q2 		$2K Buy
+98
New +$2.44K ﹤0.01% 1960

Other funds holding LOXO

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acrospire Investment Management's LOXO Position: Q3 2016 in Review

Acrospire Investment Management sold out of Loxo Oncology, Inc (LOXO) in Q3 2016, closing a stake of 98 shares — an estimated $2K sold.

Acrospire Investment Management first reported a position in LOXO in Q2 2016 and held it in 1 quarter. The position peaked at $2K in Q2 2016. 72 funds tracked by Wall St. Rank hold LOXO as of Q3 2016.

  • Acrospire Investment Management reported no remaining Loxo Oncology, Inc position as of Q3 2016 after selling out during the quarter.
  • Acrospire Investment Management sold 98 Loxo Oncology, Inc shares in Q3 2016, an estimated $2K.
  • Acrospire Investment Management first reported a position in Loxo Oncology, Inc in Q2 2016 and held it in 1 quarter.
  • Acrospire Investment Management's Loxo Oncology, Inc position peaked at $2K in Q2 2016.
  • 72 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q3 2016.

Based on Acrospire Investment Management's 13F filing for Q3 2016, filed 10 Nov 2016.